RXi makes board appointment
This article was originally published in Scrip
Executive Summary
RXi Pharmaceuticals, a US biopharmaceutical company focused on the development and commercialisation of proprietary therapeutics based on RNAi, has elected Dr Rudolph Nisi to its board of directors. Dr Nisi, a cardiologist, is chairman of the board and an attending physician at Westchester Square Medical Center. He has been a clinical professor of medicine at Cornell University Medical College for more than 10 years.